Specialized Toxicology Expertise MB Research Laboratories' focus on both in vitro and in vivo toxicology testing, especially with New Approach Methodologies, positions them as a leader in offering innovative, non-animal testing solutions. This expertise can be highly valuable for clients seeking compliant and ethical testing options aligned with global regulatory standards.

Regulatory Compliance Focus With extensive capabilities in GLP-compliant studies and expertise in OECD, ISO 10993, and EPA guidelines, MB Research is well-placed to support clients aiming to navigate complex regulatory pathways efficiently, making it a strong partner for companies developing regulated consumer and medical products.

Emerging Market Demand As the industry shifts toward alternative testing methods and stricter safety assessments, there is an increasing market opportunity for MB Research’s non-animal testing services, particularly in medical device biocompatibility and chemical safety testing, driving potential sales growth.

Client Segments MB Research serves a diverse range of clients including pharmaceutical, medical device, and chemical companies, all of which are expanding their R&D portfolios. Targeting these sectors with tailored testing solutions offers clear cross-selling and upselling opportunities.

Growth Potential Despite its smaller size, MB Research’s long-standing reputation and niche expertise open doors for strategic partnerships, collaborations, or acquisitions with larger CROs or industry players seeking specialized toxicology testing capacities.